Literature DB >> 22726461

Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.

C Pant1, M P Anderson, J A O'Connor, C M Marshall, A Deshpande, T J Sferra.   

Abstract

BACKGROUND: Diarrhea is a frequent and potentially severe complication in solid organ transplant (SOT) recipients. One of the most common infectious etiologies of diarrhea in these patients is Clostridium difficile. Our objective was to investigate the association of C. difficile infection (CDI) with the outcomes of hospitalized SOT patients.
METHODS: We extracted all adult cases with discharge diagnoses of SOT or CDI from the United States Nationwide Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality 2009 database. We collected outcome variables (mortality, length of hospital stay [LOS], hospitalization charges, complications of the transplanted organ, and colectomy), demographic information, and comorbidity data for each of the cases. The data were evaluated using univariate and multiple variable regression analyses.
RESULTS: We identified 49,198 cases with SOT of which 2.7% had CDI. Univariate comparisons of cases with SOT + CDI to those with SOT-only revealed significant differences in the evaluated outcomes including in-hospital mortality (7.4% vs. 2.4%, P < 0.001), LOS (median 9 days vs. 4 days, P < 0.001), charges (median $53,808 vs. $31,488, P < 0.001), organ complications (38.1% vs. 33.9%, P < 0.001), and colectomy (1.1% vs. 0.3%, P < 0.001). Using multiple variable regression analyses, in the SOT cohort (SOT-only and SOT + CDI), CDI was independently associated with greater mortality (adjusted odds ratio [aOR] 2.48, 95% confidence interval [CI] = 2.22, 2.76, P < 0.001), longer LOS (difference 9.6 days, 95% CI = 9.3, 9.9, P < 0.001), higher charges (difference $69,647, 95% CI = $66,190, $73,104, P < 0.001), more complications of the transplanted organ (aOR 1.36, 95% CI = 1.28, 1.44, P < 0.001), and increased need for colectomy (aOR 3.10, 95% CI = 2.35, 4.08, P < 0.001).
CONCLUSIONS: Our results demonstrate that CDI is associated with overall significantly worse outcomes in hospitalized patients with SOT.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22726461     DOI: 10.1111/j.1399-3062.2012.00761.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  25 in total

1.  Effects of Clostridium difficile infection in patients with alcoholic hepatitis.

Authors:  Vinay Sundaram; Folasade P May; Vignan Manne; Sammy Saab
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-27       Impact factor: 11.382

2.  Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report.

Authors:  Joseph A Spinner; Claire E Bocchini; Ruth A Luna; Santosh Thapa; Miriam A Balderas; Susan W Denfield; William J Dreyer; Dorottya Nagy-Szakal; Faith D Ihekweazu; James Versalovic; Tor Savidge; Richard Kellermayer
Journal:  Pediatr Transplant       Date:  2019-10-16

Review 3.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

4.  Increased resource use in lung transplant admissions in the lung allocation score era.

Authors:  Bryan G Maxwell; Joshua J Mooney; Peter H U Lee; Joseph E Levitt; Laveena Chhatwani; Mark R Nicolls; Martin R Zamora; Vincent Valentine; David Weill; Gundeep S Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

5.  Hospital-onset Clostridium difficile infection among solid organ transplant recipients.

Authors:  J P Donnelly; H E Wang; J E Locke; R B Mannon; M M Safford; J W Baddley
Journal:  Am J Transplant       Date:  2015-11       Impact factor: 8.086

6.  Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.

Authors:  E R Dubberke; K A Reske; M A Olsen; K Bommarito; A A Cleveland; F P Silveira; M G Schuster; C A Kauffman; R K Avery; P G Pappas; T M Chiller
Journal:  Transpl Infect Dis       Date:  2018-03-06       Impact factor: 2.228

Review 7.  Big data in organ transplantation: registries and administrative claims.

Authors:  A B Massie; L M Kucirka; L M Kuricka; D L Segev
Journal:  Am J Transplant       Date:  2014-08       Impact factor: 8.086

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Diagnostic yields in solid organ transplant recipients admitted with diarrhea.

Authors:  Ignacio A Echenique; Sudhir Penugonda; Valentina Stosor; Michael G Ison; Michael P Angarone
Journal:  Clin Infect Dis       Date:  2014-11-03       Impact factor: 9.079

10.  Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients.

Authors:  R J Friedman-Moraco; A K Mehta; G M Lyon; C S Kraft
Journal:  Am J Transplant       Date:  2014-01-16       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.